Adewale Fawole, MBBSThe James Cancer Center
- Medical Oncology
I am an oncologist specializing in patients with cancer and blood disorders. I completed my hematology and medical oncology fellowship at the Oakland University William Beaumont School of Medicine in Michigan, where I received the Freeman Wilner Foundation's Compassionate Care Award for my approach to patient care. Before my fellowship, I completed my residency at Cleveland Clinic and medical training at the University of Ilorin in Nigeria. Currently, I serve as an assistant professor in the Division of Hematology at the OSUCCC – James.
My most recent research focuses on colorectal cancer in patients younger than 50 years old. I've also completed research on lymphoma, low-grade gliomas and other blood and cancer-related conditions. My work has been published in numerous journals, including the Journal of Clinical Oncology. Additionally, I am a member of the American Society of Clinical Oncology and the American Society of Hematology.
The OSUCCC – James focuses on providing patients with targeted treatment plans that fits their cancer and their lives. No two cancers are the same, and The James gives us access to the newest research to ensure we give our patients the best outcomes possible. The James also lets me share my knowledge with other medical professionals and upcoming physicians, so we can improve health care delivery for years to come. I'm proud to work at such a comprehensive facility, and I strive to create a cancer-free world with each patient I meet.
Education and Background
University of Ilorin
Royal Oak, MI
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Hematology)
- American Board of Internal Medicine (Subspecialty: Medicine Oncology)
I see patients at
JamesCare at University Hospital East
181 Taylor Avenue, Columbus, Ohio 43203
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Fawole has reported no financial relationships with medical device, research and/or drug companies.